Hepatic impairment (HI)
Clinical trials for Hepatic impairment (HI) explained in plain language.
Never miss a new study
Get alerted when new Hepatic impairment (HI) trials appear
Sign up with your email to follow new studies for Hepatic impairment (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver trouble changes drug levels: vorolanib put to the test
Knowledge-focused Recruiting nowResearchers are studying how a single 200 mg dose of vorolanib, an experimental oral cancer drug, moves through the body in people with mild or moderate liver impairment compared with people whose livers work normally. The trial enrolls 36 participants split into three groups bas…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase 1 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Liver function may change how D-2570 works in the body
Knowledge-focused Recruiting nowThis study tests how the experimental drug D-2570 moves through the body and whether it is safe in people with liver problems compared to those with healthy livers. Researchers will give a single dose of D-2570 to 24 adults aged 18 to 70 and measure drug levels in the blood over …
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase 1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC